[go: up one dir, main page]

AU2326995A - A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof - Google Patents

A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof

Info

Publication number
AU2326995A
AU2326995A AU23269/95A AU2326995A AU2326995A AU 2326995 A AU2326995 A AU 2326995A AU 23269/95 A AU23269/95 A AU 23269/95A AU 2326995 A AU2326995 A AU 2326995A AU 2326995 A AU2326995 A AU 2326995A
Authority
AU
Australia
Prior art keywords
lowering
preparation
pharmaceutical composition
blood pressure
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU23269/95A
Other versions
AU699386B2 (en
Inventor
Borbala Barta
Janos Egri
Csaba Dr. Farsang
Lidia Fedina
Geza Floris
Frigyes Dr. Gorgenyi
Antal Mosonyi
Margit Dr. Nagy
Ibolya Nyaradi
Zsuzsa Orr
Katalin Dr. Szemeredi
Gabor Szenasi
Gizella Toth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2326995A publication Critical patent/AU2326995A/en
Application granted granted Critical
Publication of AU699386B2 publication Critical patent/AU699386B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU23269/95A 1994-07-26 1995-06-27 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof Ceased AU699386B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP9402193 1994-07-26
HU9402193A HU214582B (en) 1994-07-26 1994-07-26 Spayable antihypertensive composition and process for it`s production

Publications (2)

Publication Number Publication Date
AU2326995A true AU2326995A (en) 1996-02-08
AU699386B2 AU699386B2 (en) 1998-12-03

Family

ID=10985460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23269/95A Ceased AU699386B2 (en) 1994-07-26 1995-06-27 A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof

Country Status (18)

Country Link
JP (1) JPH08169829A (en)
AT (1) AT402690B (en)
AU (1) AU699386B2 (en)
BE (1) BE1011413A4 (en)
CZ (1) CZ286399B6 (en)
DE (1) DE19527140A1 (en)
EE (1) EE9500029A (en)
FR (1) FR2722988B1 (en)
GB (1) GB2291593B (en)
HR (1) HRP950374A2 (en)
HU (1) HU214582B (en)
IT (1) IT1277348B1 (en)
LT (1) LT4042B (en)
LV (1) LV11026B (en)
PL (1) PL181069B1 (en)
SK (1) SK280463B6 (en)
UA (1) UA39880C2 (en)
YU (1) YU50795A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
JP2001517689A (en) * 1997-10-01 2001-10-09 フレミントン ファーマシューティカル コーポレイション Polar or non-polar buccal spray or capsule
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
CA2597956C (en) 2005-02-17 2013-07-09 Velcera Pharmaceuticals Transmucosal administration of drug compositions for treating and preventing disorders in animals
DE102006027794A1 (en) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertensive combination wafer
FR2906140B1 (en) * 2006-09-22 2008-12-05 Philippe Perovitch GALENIC FORM FOR TRANSMUCOSUS ADMINISTRATION OF ACTIVE INGREDIENTS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
EP0175671A1 (en) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmaceutical preparation and method for the administration of this pharmaceutical preparation
DE3544692A1 (en) * 1985-12-18 1987-06-19 Bayer Ag DIHYDROPYRIDINE SPRAY, METHOD FOR THE PRODUCTION THEREOF AND ITS PHARMACEUTICAL USE
DE3775960D1 (en) * 1986-03-10 1992-02-27 Burghart Kurt PHARMACEUTICAL PREPARATION AND METHOD FOR THE PRODUCTION THEREOF.
DE3779999T2 (en) * 1986-11-14 1992-12-10 Theratech Inc INCREASE IN PENETRATION CAPABILITY BY MEANS OF A SUBSTANCE AND SHORT-CHAIN ALCOHOLIC SYSTEM CONTAINING CHANGES IN THE CELL HELL.
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPS63170316A (en) * 1986-12-30 1988-07-14 Fujimoto Seiyaku Kk Percutaneously absorbable pharmaceutical of nifedipine for external use
DE3714402A1 (en) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh DRUG FORMULATION
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
AT391269B (en) * 1988-12-30 1990-09-10 Burghart Kurt PHARMACEUTICAL PREPARATION
US5298258A (en) * 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition

Also Published As

Publication number Publication date
CZ181195A3 (en) 1996-02-14
HU9402193D0 (en) 1994-09-28
JPH08169829A (en) 1996-07-02
LT95084A (en) 1996-06-25
HUT75457A (en) 1997-05-28
PL181069B1 (en) 2001-05-31
LT4042B (en) 1996-09-25
ATA121495A (en) 1996-12-15
EE9500029A (en) 1996-02-15
UA39880C2 (en) 2001-07-16
DE19527140A1 (en) 1996-02-01
LV11026B (en) 1996-04-20
AU699386B2 (en) 1998-12-03
FR2722988A1 (en) 1996-02-02
YU50795A (en) 1998-05-15
GB2291593B (en) 1998-03-11
GB9515205D0 (en) 1995-09-20
IT1277348B1 (en) 1997-11-10
HU214582B (en) 1998-04-28
AT402690B (en) 1997-07-25
GB2291593A (en) 1996-01-31
CZ286399B6 (en) 2000-04-12
ITMI951621A1 (en) 1997-01-26
FR2722988B1 (en) 1999-10-08
SK92295A3 (en) 1996-05-08
SK280463B6 (en) 2000-02-14
HRP950374A2 (en) 1997-10-31
BE1011413A4 (en) 1999-09-07
ITMI951621A0 (en) 1995-07-26
LV11026A (en) 1996-02-20
PL309757A1 (en) 1996-02-05

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
IL174082A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition
IL116673A0 (en) A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof
AU4516796A (en) Chitosan salts and process for the preparation thereof
AU3967795A (en) Method of sterilizing a pharmaceutical composition
AU3173095A (en) Novel pharmaceutical product
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU7060896A (en) Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
AU4267396A (en) Modified cannula
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU3081995A (en) Method for preparing a material for medical or veterinary use, resulting material, and uses thereof
AU5229496A (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU6242190A (en) New thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
AU2531295A (en) Pharmaceutical composition
AU2364597A (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU2311195A (en) Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
AU3011095A (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU2326995A (en) A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof
AU3873295A (en) Wood-based form parts and a method for the preparation thereof
AU4344996A (en) Vessel-puncturing cannula
AU1475595A (en) Pharmaceutical preparation
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
AU3034595A (en) New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them
AU3705695A (en) Pharmaceutical composition comprising atovaquone

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired